We serve Chemical Name:Lisinopril CAS:76547-98-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Lisinopril
CAS.NO:76547-98-3
Synonyms:CARACE;1-{N-[(1S)-1-Carboxy-3-phenylpropyl]-L-lysyl}-L-prolin;Lisinopril;Cipral;PRINIL;mk522;(2S)-1-[(2S)-6-amino-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}hexanoyl]pyrrolidine-2-carboxylic acid;Longes;(2S)-1-[(2S)-6-Amino-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}hexanoyl]-2-pyrrolidinecarboxylic acid;MFCD00214086;N-[(1S)-1-Carboxy-3-phenylpropyl]-L-lysyl-L-prolinato;Tensyn;N-[(1S)-1-Carboxy-3-phenylpropyl]-L-lysyl-L-proline;Renacor;CORIC;mk0521;L-Proline, N-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-;Linvas;EINECS 278-488-1;MK-521
Molecular Formula:C21H31N3O5
Molecular Weight:405.488
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:666.4±55.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.578
PSA:132.96000
Exact Mass:405.226379
LogP:1.19
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like CARACE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MK-521 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Renacor Use and application,Linvas technical grade,usp/ep/jp grade.
Related News: The inhaled two-dose candidate is modified from CanSinoBIO’s injected COVID-19 jab Ad5-nCoV vaccine, which is already approved in China and other countries around the world. (Z)-7-((1R,2S,3S,4S)-3-(5-((6-hydroxynaphthalen-1-yl)methyl)thiophene-2-carboxamido)bicyclo[2.2.1]heptan-2-yl)hept-5-enoic acid manufacturers In the trial, 362 eligible patients were randomised (1:1) and received a fixed-dose intravenous infusion of 300mg anifrolumab or placebo every four weeks. N-[(benzyloxycarbonyl)methyl]-N-[(2S,4S)-4-[2-(benzyloxycarbonyl)-N-[(benzyloxycarbonyl)methyl]pyrrolidinyl]]-(2R)-N,N-[bis[(benzyloxycarbonyl)methyl]amino]-3-(tert-butyldiphenylsilyloxy)propylamine suppliers Officials did, however, acknowledge that there’s growing evidence an extra jab may enhance the antibody response in immunocompromised people. Some small studies suggest up to 50% of people with no antibody response after the authorized regimen of two mRNA jabs developed a response after an additional dose, said CDC’s Sara Oliver, M.D. C,C,C-Trifluoro-N-(4-methoxy-benzoyl)-methanesulfonamide vendor & factory.
